Altamira Therapeutics Ltd. (NASDAQ: CYTO) Stock Information | RedChip

Altamira Therapeutics Ltd. (NASDAQ: CYTO)


$0.5100
+0.0294 ( +6.12% ) 14.9K

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.

Market Data


Open


$0.5100

Previous close


$0.4806

Volume


14.9K

Market cap


$1.85M

Day range


$0.4860 - $0.5200

52 week range


$0.4500 - $17.2000

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 2 Oct 04, 2024
6-k Form 6-K 53 Sep 24, 2024
6-k Form 6-K 9 Sep 19, 2024
20-f/a Annual reports 20 Jul 01, 2024
6-k Form 6-K 1 May 16, 2024
20-f/a Annual reports 161 Apr 22, 2024
6-k Form 6-K 6 Apr 16, 2024
6-k Form 6-K 2 Apr 10, 2024
20-f Annual reports 166 Apr 10, 2024
6-k Form 6-K 2 Jan 19, 2024

Latest News